Figure 2From: Novel dimeric DOTA-coupled peptidic Y1-receptor antagonists for targeting of neuropeptide Y receptor-expressing cancers Structure of the DOTA-free dimeric Y 1 receptor affine antagonist (3) and its DOTA-conjugated dimeric counterparts. Structure of (A) the DOTA-free dimeric Y1 receptor affine antagonist (3) and its DOTA-conjugated dimeric counterparts (B) 10 and (C) 11.Back to article page